advance market commitment amc binding contract typically offered government financial entity used guarantee viable market product successfully developed generally amcs used circumstances cost developing new product high worthwhile private sector without guarantee certain quantity purchases advance amcs used creation vaccines medicine high upfront development costs result commitment market vaccines drugs neglected diseases would comparable size certainty market medicines rich countries would encourage biotech pharmaceutical companies invest development new vaccines tackle worlds pressing health problems pneumonia diarrheal disease hivaids malaria normal course business decisions amc also launched carbonremoval meets certain technical specifications amcs proposed michael kremer rachel glennerster encourage february five countries canada italy norway russia united kingdom bill melinda gates foundation committed billion launch first advance market commitment speed development availability new vaccine expected save lives million children pilot provides years funding support development future vaccines pneumococcal disease pneumococcal disease major cause pneumonia meningitis kills million people every year pilot includes provisions assure long term sustainable supply price poorest countries amc pneumococcal disease offers improved market vaccines development vaccines bought meet predetermined standards efficacy safety developing countries ask years amc funding likely depleted independent expert committee representation developing industrialised countries recommended pneumococcal disease target initial amc pilot going forward amc overseen independent assessment committee set monitor standards vaccines world health organization facilitate establishment target product profile assess quality safety immunogenicity amc vaccines gavi alliance world bank responsible supporting programmatic financial functions amc idea contract previously proposed academic literature michael kremer opinion pieces major newspapers gained additional momentum publication report making markets vaccines ideas action working group organized center global target product profile tpp pneumococcal advanced market commitment amc developed world health organization request amc secretariat december independent assessment committee iac officially endorsed making definitive set guidelines determining characteristics amceligible pneumococcal conjugate vaccines tpp sets standards vaccine must meet order eligible sale amc program iac determines whether candidate vaccine meets tpp specifications meet tpp vaccine must meet exceed requirements specific requirements tpp relate projected public health impact vaccine safety suitability product use developing country health december amc carbonremoval first proposed politico essay economists susan athey rachel glennerster christopher snyder nan ransohoff head stripe april stripe launched frontier climate amc buy initial permanent carbon removal ransohoff leads project told atlantic carbonremoval market probably need reach trillion per httpsenwikipediaorgwikiadvancemarketcommitment